TECH Earnings & Financial Statements
Bio-Techne Corporation
$72.56
+$0.10(+0.14%)
62
Overall
55
Value
66
Tech
65
Quality
Market Cap
$11.36B
Volume
2.42M
52W Range
$43.20 - $72.69
Target Price
$70.91
TECH earnings and financial statements: Bio-Techne Corporation's income statement, balance sheet and cash flow statement, annual and quarterly.
TECH Annual Financial Statements
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $1.22B | $1.16B | $1.14B | $1.11B | $931.03M |
| Cost of revenue | $429.36M | $389.33M | $366.89M | $349.10M | $298.18M |
| Operating income | $242.80M | $206.69M | $298.94M | $296.59M | $237.30M |
| EBITDA | $216.88M | $313.14M | $457.11M | $413.76M | $249.87M |
| Net income | $73.40M | $168.10M | $285.26M | $272.05M | $140.41M |
| EPS (diluted) | $0.46 | $1.05 | $1.76 | $1.66 | $0.87 |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | $2.56B | $2.70B | $2.64B | $2.29B | $2.26B |
| Total liabilities | $639.06M | $635.02M | $672.18M | $593.79M | $691.72M |
| Shareholders’ equity | $1.92B | $2.07B | $1.97B | $1.70B | $1.56B |
| Cash and equivalents | $162.19M | $151.79M | $180.57M | $172.57M | $199.09M |
| Long-term debt | $429.96M | $406.62M | $443.77M | $301.54M | $396.45M |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating cash flow | $287.56M | $298.98M | $254.39M | $325.27M | $352.50M |
| Capital expenditure | -$31.01M | -$62.88M | -$38.24M | -$44.91M | -$44.30M |
| Free cash flow | $256.55M | $236.10M | $216.15M | $280.36M | $308.20M |
| Dividends paid | $50.39M | $50.42M | $50.28M | $50.19M | $49.62M |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | TECH | $72.56 | +0.1% | 2.42M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |